Skip to main content
. 2017 Aug 16;33(7):1168–1175. doi: 10.1093/ndt/gfx238

FIGURE 3.

FIGURE 3

Patients with immune deposits in the PCWs were significantly more likely to reach the primary outcome than those with deposits in the mesangium alone (P = 0.02). At ≥40 months of follow-up, 26 patients remained in the cohort. In all, 24 of these patients had immune deposits limited to the mesangium, 2 of whom reached the primary outcome. Two patients had immune deposits in the PCWs in addition to the mesangium, one of whom reached the primary outcome.